Characteristic | Survivors (N = 120) | Non-survivors (N = 13) | P value |
---|---|---|---|
Age (days) | 38.63 ± 26.87 | 17.46 ± 17.10 | 0.006 |
≤28 days | 41 (34.1 %) | 9(69.2) | 0.017 |
Female | 44 (36.7 %) | 0 (0 %) | 0.005 |
Weight (kg) | 3.92 ± 0.93 | 3.61 ± 0.63 | 0.234 |
RACHS-1 ≥ 4 | 31(25.8 %) | 8(61.5 %) | 0.020 |
Preoperative serum albumin (g/L) | 38.13 ± 4.97 | 39.31 ± 3.78 | 0.406 |
Preoperative thyroid function | |||
FT3 (pmol/L) | 5.11 ± 1.55 | 3.91 ± 0.99 | 0.007 |
FT4 (pmol/L) | 21.52 ± 5.79 | 19.02 ± 5.85 | 0.142 |
TT3 (nmol/L) | 1.90 ± 0.57 | 1.55 ± 0.35 | 0.032 |
TT4 (nmol/L) | 122.07 ± 34.77 | 103.47 ± 29.10 | 0.066 |
TSH (µIU/ml) | 5.48 ± 4.94 | 7.89 ± 11.90 | 0.483 |
Operative factors | |||
CPB time (min) | 111.53 ± 83.87 | 139.07 ± 58.61 | 0.251 |
ACC time (min) | 45.01 ± 21.61 | 55.40 ± 19.73 | 0.100 |